These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17383287

  • 1. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
    Patel P, White DL, Deswal A.
    Am Heart J; 2007 Apr; 153(4):515-22. PubMed ID: 17383287
    [Abstract] [Full Text] [Related]

  • 2. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators.
    J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 6. Beta-blocker use and outcomes among hospitalized heart failure patients.
    Butler J, Young JB, Abraham WT, Bourge RC, Adams KF, Clare R, O'Connor C, ESCAPE Investigators.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2462-9. PubMed ID: 16781374
    [Abstract] [Full Text] [Related]

  • 7. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.
    Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, Massie BM.
    Circulation; 2003 Jun 10; 107(22):2799-804. PubMed ID: 12756157
    [Abstract] [Full Text] [Related]

  • 8. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2008 Oct 10; 156(4):662-73. PubMed ID: 18926148
    [Abstract] [Full Text] [Related]

  • 9. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery.
    Chan AY, McAlister FA, Norris CM, Johnstone D, Bakal JA, Ross DB, Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators.
    J Thorac Cardiovasc Surg; 2010 Jul 10; 140(1):182-7, 187.e1. PubMed ID: 20427056
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D, Peltier M, Cohen-Solal A, Béguin M, Lévy F, Slama M, Chapelain K, Tribouilloy C.
    Int J Cardiol; 2005 Sep 01; 103(3):286-92. PubMed ID: 16098391
    [Abstract] [Full Text] [Related]

  • 12. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
    Matthews JC, Johnson ML, Koelling TM.
    Am Heart J; 2007 Dec 01; 154(6):1174-83. PubMed ID: 18035092
    [Abstract] [Full Text] [Related]

  • 13. Changes in heart failure medications in patients hospitalised and discharged.
    Scherer M, Sobek C, Wetzel D, Koschack J, Kochen MM.
    BMC Fam Pract; 2006 Nov 23; 7():69. PubMed ID: 17123439
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J, HELUMA study group.
    Eur Heart J; 2005 Dec 23; 26(24):2689-97. PubMed ID: 16183697
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB.
    Am J Cardiol; 2008 Dec 01; 102(11):1524-9. PubMed ID: 19026308
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA, Peñafiel P, Nicolas F, de la Morena G, Ansaldo P, Redondo B, Sánchez Mas J, Valdés M.
    Rev Esp Cardiol; 2008 Mar 01; 61(3):260-8. PubMed ID: 18361899
    [Abstract] [Full Text] [Related]

  • 20. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.
    Witham MD, Gillespie ND, Struthers AD.
    Age Ageing; 2004 Sep 01; 33(5):467-72. PubMed ID: 15217777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.